ArticleScientific reports2026
Lipid profiles and risk of gestational diabetes mellitus in women with isolated TPOAb positivity during early pregnancy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Isolated thyroid peroxidative antibody (TPOAb) positivity has been linked to adverse pregnancy outcomes including gestational diabetes mellitus (GDM). Elevated lipids are reported as pivotal risk factors. Current researches indicated 75 g oral glucose tolerance test (OGTT) in early pregnancy has limited predictive ability for GDM. The lipid profiles in isolated TPOAb positive pregnant women and their correlation with GDM were unclear. To delineate the specific lipid profile characteristics in pregnant women with isolated TPOAb positivity and to identify potential lipid biomarkers for early prediction of GDM. Euthyroid pregnant women were enrolled in the first trimester and underwent OGTT in the second trimester. Participants were divided into four groups based on TPOAb status and OGTT results. Untargeted liquid chromatography-mass spectrometry (LC-MS) was used to identify lipid molecules. Of 88 women, 43.5% (20/46) with TPOAb positivity and 35.7% (15/42) without were diagnosed with GDM. Low-density lipoprotein (LDL) levels were positively associated with GDM risk in TPOAb positive women. LC-MS analysis identified 13 different lipid molecules significantly correlated with OGTT results. A nomogram was constructed to predict the occurrence of GDM. Elevated first-trimester LDL levels are associated with increased GDM risk in isolated TPOAb-positive women. Furthermore, PC (20:0/16:0) and TG (16:0/16:0/18:1), combined with TSH and TPOAb titers, are potential biomarkers for early prediction of GDM in this specific population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.